Azilsartan medoxomil - API
| Product Name |
Azilsartan medoxomil - API
|
| Product Code |
DA-A370-01
|
| Chemical name |
Azilsartan medoxomil
|
| Synonyms |
(5-Methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 2-ethoxy-1-({4-[2-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl]phenyl}methyl)-1H-1,3-benzodiazole-7-carboxylate;
|
| Impurity |
NA
|
| CAS Number |
863031-21-4
|
| Alternate CAS # |
NA
|
| Molecular form |
C30H24N4O8
|
| Appearance |
NA
|
| Melting Point |
NA
|
| Mol. Weight |
568.54
|
| Storage |
2-8°C Refrigerator
|
| Solubility |
NA
|
| Stability |
NA
|
| Category |
impurities,metabolites,pharmaceutical standards,intermediates,Fine Chemicals
|
| Boiling Point |
NA
|
| Applications |
Azilsartan medoxomil is an angiotensin II receptor antagonist indicated for the treatment of mild to moderate essential hypertension. Azilsartan medoxomil is a prodrug of Azilsartan marketed as "Edarbi" by Takeda. Azilsartan medoxomil has so far been shown to be superior to olmesartan and valsartan in lowering blood pressure.
|
| Dangerous Goods Info |
NA
|
| References |
NA
|
| Extra Notes |
NA
|
| Documents (MSDS) |
No Data Available
|
| Keywords |
NA |
